Status:
COMPLETED
The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)
Lead Sponsor:
Vejle Hospital
Collaborating Sponsors:
Odense University Hospital
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The primary objective of the the study is to investigate the changes in bone remodeling during Velcade treatment.
Detailed Description
20 patients will be included in the study over a 2 year period. Before, during and after treatment we will measure NTX-I, CTX-I, CTX-MMP, bALP, DKK-1, PINP, TRAcP and PTH. NTX, CTX and CTX-MMP are mea...
Eligibility Criteria
Inclusion
- Previously untreated multiple myeloma
Exclusion
- Use of bisfosfonates
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00436059
Start Date
February 1 2007
End Date
July 1 2009
Last Update
July 8 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Odense
Odense, Odense, Denmark, 5000
2
Vejle Hospital
Vejle, Vejle, Denmark, 7100